Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 171

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

Open access
Wu, Hongjie, Liu, Junkai, Jiang, Tengsheng, Zou, Quan, Qi, Shujie, Cui, Zhiming, Tiwari, Prayag, Ding, Yijie·2024·Neural Networks

Abstract

The accurate prediction of drug-target affinity (DTA) is a crucial step in drug discovery and design. Traditional experiments are very expensive and time-consuming. Recently, deep learning methods have achieved notable performance improvements in DTA prediction. However, one challenge for deep learning-based models is appropriate and accurate representations of drugs and targets, especially the lack of effective exploration of target representations. Another challenge is how to comprehensively capture the interaction information between different instances, which is also important for predicting DTA. In this study, we propose AttentionMGT-DTA, a multi-modal attention-based model for DTA prediction. AttentionMGT-DTA represents drugs and targets by a molecular graph and binding pocket graph, respectively. Two attention mechanisms are adopted to integrate and interact information between different protein modalities and drug-target pairs. The experimental results showed that our proposed model outperformed state-of-the-art baselines on two benchmark datasets. In addition, AttentionMGT-DTA also had high interpretability by modeling the interaction strength between drug atoms and protein residues. Our code is available at https://github.com/JK-Liu7/AttentionMGT-DTA.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neunet.2023.11.018

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 56

  1. Bagherian, 2020, Machine learning approaches and databases for prediction of drug–target interaction: A survey paper, Briefings in Bioinformatics, 22, 247, 10.1093/bib/bbz157 · DOI · Paper page
  2. Bahi, 2021, Convolutional neural network with stacked autoencoders for predicting drug-target interaction and binding affinity, International Journal of Data Mining, Modelling and Management, 13, 81, 10.1504/IJDMMM.2021.112914 · DOI
  3. Burley, 2018, RCSB Protein Data Bank: Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy, Nucleic Acids Research, 47, D464, 10.1093/nar/gky1004 · DOI · Paper page
  4. Chao, 2021, A machine learning method for differentiating and predicting human-infective coronavirus based on physicochemical features and composition of the spike protein, Chinese Journal of Electronics, 30, 815, 10.1049/cje.2021.06.003 · DOI
  5. Cloninger, 2021, A deep network construction that adapts to intrinsic dimensionality beyond the domain, Neural Networks, 141, 404, 10.1016/j.neunet.2021.06.004 · DOI
  6. Dhakal, 2021, Artificial intelligence in the prediction of protein–ligand interactions: Recent advances and future directions, Briefings in Bioinformatics, 23, bbab476, 10.1093/bib/bbab476 · DOI · Paper page
  7. Ding, 2023, Identification of drug-side effect association via multi-view semi-supervised sparse model, IEEE Transactions on Artificial Intelligence, 1
  8. Ding, 2020, Identification of drug–target interactions via dual Laplacian regularized least squares with multiple kernel fusion, Knowledge-Based Systems, 204, 10.1016/j.knosys.2020.106254 · DOI
  9. Ding, 2020, Identification of drug-target interactions via fuzzy bipartite local model, Neural Computing and Applications, 32, 10303, 10.1007/s00521-019-04569-z · DOI
  10. Ding, 2021, Identification of drug-target interactions via multi-view graph regularized link propagation model, Neurocomputing, 461, 618, 10.1016/j.neucom.2021.05.100 · DOI
  11. Ding, 2022, Identification of drug–target interactions via multiple kernel-based triple collaborative matrix factorization, Briefings in Bioinformatics, 23, 10.1093/bib/bbab582 · DOI
  12. Ding, 2022, Shared subspace-based radial basis function neural network for identifying ncRNAs subcellular localization, Neural Networks, 156, 170, 10.1016/j.neunet.2022.09.026 · DOI
  13. ElAbd, 2020, Amino acid encoding for deep learning applications, BMC Bioinformatics, 21, 1, 10.1186/s12859-020-03546-x · DOI
  14. Ezzat, 2018, Computational prediction of drug–target interactions using chemogenomic approaches: An empirical survey, Briefings in Bioinformatics, 20, 1337, 10.1093/bib/bby002 · DOI · Paper page
  15. Gönen, 2005, Concordance probability and discriminatory power in proportional hazards regression, Biometrika, 92, 965, 10.1093/biomet/92.4.965 · DOI · Paper page
  16. Huang, 2022, CoaDTI: Multi-modal co-attention based framework for drug–target interaction annotation, Briefings in Bioinformatics, 23, bbac446, 10.1093/bib/bbac446 · DOI
  17. Huang, 2020, MolTrans: Molecular interaction transformer for drug–target interaction prediction, Bioinformatics, 37, 830, 10.1093/bioinformatics/btaa880 · DOI · Paper page
  18. Jiang, 2021, InteractionGraphNet: A novel and efficient deep graph representation learning framework for accurate protein–ligand interaction predictions, Journal of Medicinal Chemistry, 64, 18209, 10.1021/acs.jmedchem.1c01830 · DOI · Paper page
  19. Karimi, 2019, DeepAffinity: Interpretable deep learning of compound–protein affinity through unified recurrent and convolutional neural networks, Bioinformatics, 35, 3329, 10.1093/bioinformatics/btz111 · DOI · Paper page
  20. Kimber, 2021, Deep learning in virtual screening: Recent applications and developments, International Journal of Molecular Sciences, 22, 10.3390/ijms22094435 · DOI · Paper page
  21. Lee, 2019, DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequences, PLoS Computational Biology, 15, 1, 10.1371/journal.pcbi.1007129 · DOI · Paper page
  22. Li, 2020, MONN: A multi-objective neural network for predicting compound-protein interactions and affinities, Cell Systems, 10, 308, 10.1016/j.cels.2020.03.002 · DOI · Paper page
  23. Li, 2022, Effective drug–target interaction prediction with mutual interaction neural network, Bioinformatics, 38, 3582, 10.1093/bioinformatics/btac377 · DOI
  24. Li, 2022, Effective drug–target interaction prediction with mutual interaction neural network, Bioinformatics, 38, 3582, 10.1093/bioinformatics/btac377 · DOI
  25. Li, 2022, Co-VAE: Drug-target binding affinity prediction by co-regularized variational autoencoders, IEEE Transactions on Pattern Analysis and Machine Intelligence, 44, 8861, 10.1109/TPAMI.2021.3120428 · DOI
  26. Mao, 2021, Theory of deep convolutional neural networks III: Approximating radial functions, Neural Networks, 144, 778, 10.1016/j.neunet.2021.09.027 · DOI
  27. Michaud-Agrawal, 2011, MDAnalysis: A toolkit for the analysis of molecular dynamics simulations, Journal of Computational Chemistry, 32, 2319, 10.1002/jcc.21787 · DOI · Paper page
  28. Newman, 2020, Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019, Journal of Natural Products, 83, 770, 10.1021/acs.jnatprod.9b01285 · DOI · Paper page
  29. Nguyen, 2020, GraphDTA: Predicting drug–target binding affinity with graph neural networks, Bioinformatics, 37, 1140, 10.1093/bioinformatics/btaa921 · DOI · Paper page
  30. Nguyen, 2022, GEFA: Early fusion approach in drug-target affinity prediction, IEEE/ACM Transactions on Computational Biology and Bioinformatics, 19, 718, 10.1109/TCBB.2021.3094217 · DOI
  31. Nguyen, 2022, GEFA: Early fusion approach in drug-target affinity prediction, IEEE/ACM Transactions on Computational Biology and Bioinformatics, 19, 718, 10.1109/TCBB.2021.3094217 · DOI
  32. Öztürk, 2018, DeepDTA: Deep drug–target binding affinity prediction, Bioinformatics, 34, i821, 10.1093/bioinformatics/bty593 · DOI · Paper page
  33. Pandey, 2022, Ligand binding prediction using protein structure graphs and residual graph attention networks, Molecules, 27, 10.3390/molecules27165114 · DOI
  34. Qian, 2022, Identification of drug-side effect association via restricted Boltzmann machines with penalized term, Briefings in Bioinformatics, 23, 10.1093/bib/bbac458 · DOI
  35. Rifaioglu, 2020, DEEPScreen: High performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations, Chemical Science, 11, 2531, 10.1039/C9SC03414E · DOI · Paper page
  36. Saberi Fathi, 2014, A simple method for finding a protein’s ligand-binding pockets, BMC Structural Biology, 14, 1, 10.1186/1472-6807-14-18 · DOI
  37. Shen, 2022, Boosting protein–ligand binding pose prediction and virtual screening based on residue–atom distance likelihood potential and graph transformer, Journal of Medicinal Chemistry, 65, 10691, 10.1021/acs.jmedchem.2c00991 · DOI · Paper page
  38. Tang, 2014, Making sense of large-scale kinase inhibitor bioactivity data sets: A comparative and integrative analysis, Journal of Chemical Information and Modeling, 54, 735, 10.1021/ci400709d · DOI · Paper page
  39. Wang, 2022, MGPLI: Exploring multigranular representations for protein–ligand interaction prediction, Bioinformatics, 38, 4859, 10.1093/bioinformatics/btac597 · DOI
  40. Wang, 2021, Exploring associations of non-coding RNAs in human diseases via three-matrix factorization with hypergraph-regular terms on center kernel alignment, Briefings in Bioinformatics, 22, 10.1093/bib/bbaa409 · DOI
  41. Wang, 2022, ELECTRA-DTA: A new compound-protein binding affinity prediction model based on the contextualized sequence encoding, Journal of cheminformatics, 14, 1, 10.1186/s13321-022-00591-x · DOI
  42. Wang, 2022, Structure-aware multimodal deep learning for drug–protein interaction prediction, Journal of Chemical Information and Modeling, 62, 1308, 10.1021/acs.jcim.2c00060 · DOI
  43. Wang, 2021, DeepDTAF: A deep learning method to predict protein–ligand binding affinity, Briefings in Bioinformatics, 22, bbab072, 10.1093/bib/bbab072 · DOI · Paper page
  44. Wouters, 2020, Research and development costs of new drugs—Reply, JAMA, 324, 518, 10.1001/jama.2020.8651 · DOI
  45. Wu, 2022, BridgeDPI: A novel Graph Neural Network for predicting drug–protein interactions, Bioinformatics, 38, 2571, 10.1093/bioinformatics/btac155 · DOI
  46. Wu, 2021, Mining toxicity information from large amounts of toxicity data, Journal of Medicinal Chemistry, 64, 6924, 10.1021/acs.jmedchem.1c00421 · DOI
  47. Wu, 2021, Empirical potential energy function toward ab initio folding g protein-coupled receptors, IEEE/ACM Transactions on Computational Biology and Bioinformatics, 18, 1752, 10.1109/TCBB.2020.3008014 · DOI
  48. Yang, 2021, Drug–disease associations prediction via multiple kernel-based dual graph regularized least squares, Applied Soft Computing, 112, 10.1016/j.asoc.2021.107811 · DOI
  49. Yang, 2021, ML-DTI: Mutual learning mechanism for interpretable drug–target interaction prediction, The Journal of Physical Chemistry Letters, 12, 4247, 10.1021/acs.jpclett.1c00867 · DOI
  50. Yang, 2022, MGraphDTA: Deep multiscale graph neural network for explainable drug–target binding affinity prediction, Chemical Science, 13, 816, 10.1039/D1SC05180F · DOI · Paper page
  51. Yazdani-Jahromi, 2022, AttentionSiteDTI: An interpretable graph-based model for drug-target interaction prediction using NLP sentence-level relation classification, Briefings in Bioinformatics, 23, bbac272, 10.1093/bib/bbac272 · DOI
  52. Zhang, 2022, Graph neural network approaches for drug-target interactions, Current Opinion in Structural Biolog, 73
  53. Zhang, 2021, A deep learning framework for gene ontology annotations with sequence- and network-based information, IEEE/ACM Transactions on Computational Biology and Bioinformatics, 18, 2208, 10.1109/TCBB.2020.2968882 · DOI
  54. Zhang, 2021, Learning interaction dynamics with an interactive LSTM for conversational sentiment analysis, Neural Networks, 133, 40, 10.1016/j.neunet.2020.10.001 · DOI
  55. Zhao, 2021, HyperAttentionDTI: Improving drug–protein interaction prediction by sequence-based deep learning with attention mechanism, Bioinformatics, 38, 655, 10.1093/bioinformatics/btab715 · DOI · Paper page
  56. Zheng, 2020, Predicting drug–protein interaction using quasi-visual question answering system, Nature Machine Intelligence, 2, 134, 10.1038/s42256-020-0152-y · DOI · Paper page

Cited by

See all 171

Metadata

Authors
Wu, H., Liu, J., Jiang, T., Zou, Q., Qi, S., Cui, Z., Tiwari, P., & Ding, Y.
Venue
Neural Networks
Publisher
Elsevier BV
Published
2024-01
Volume
169
Pages
623-636
ISSN
0893-6080 (ISSN-L)
OpenAlex
W4388595306
Cited by
171
References
12
FWCI
22.51
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism. https://app.cochat.ai/papers/10.1016/j.neunet.2023.11.018
The paper
Wu, H., Liu, J., Jiang, T., Zou, Q., Qi, S., Cui, Z., Tiwari, P., & Ding, Y. (2024). AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism. Neural Networks. https://doi.org/10.1016/j.neunet.2023.11.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.